Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Certification & Accreditation
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Features
AMS Features
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
Safety of dupilumab in atopic patients during COVID-19 outbreak
By
- AMS
posted
Jun 19, 2020 09:24 AM
0
Recommend
.
0 comments
0 views
Related Content
Management strategies of autoimmune bullous diseases during the outbreak of 2019 Novel Coronavirus disease (COVID-19)
- AMS
Added Jun 01, 2020
Blog Entry
Herpes zoster cases increased during COVID-19 outbreak. Is it possible a relation?
- AMS
Added Jul 07, 2020
Blog Entry
Clinical management of psoriasis patients during the COVID-19 pandemic
- AMS
Added Jun 22, 2020
Blog Entry
Change of dermatological practice after the COVID-19 outbreak resolves
- AMS
Added Aug 04, 2020
Blog Entry
American Society of Plastic Surgeons Releases New Guidance for Resuming Elective Procedures Amid COVID-19
- AMS
Added Jun 17, 2020
Blog Entry
Permalink
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic